武汉人福药业

Wuhan Humanwell Pharmaceutical is a leading Chinese pharmaceutical company and a core subsidiary of Humanwell Healthcare Group. The company specializes in the research, development, and manufacturing of high-end narcotics, anesthetics, and analgesics. It maintains a dominant market position in China, particularly with its fentanyl-based products and innovative sedative agents like remimazolam. Beyond anesthesia, the company focuses on central nervous system disorders, fertility regulation, and specialized medicines. Wuhan Humanwell operates state-of-the-art GMP manufacturing facilities and invests heavily in innovative drug R&D to expand its global footprint. The company has established significant international partnerships to bring novel therapies to the Chinese market and export its own products.